SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YellowLegalPad

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: John McCarthy12/30/2007 3:56:25 PM
   of 1182
 
Brain Cancer Vaccines

DCVAX
- Northwest Biotherapeutics Inc
Dendritic Cell Vaccine

CDX-110
- Celldex Therapeutics
Peptide Vaccine

NO NAME - Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Dendritic Cell Vaccine
clinicaltrials.gov

NO NAME - Dartmouth-Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center
Dendritic Cell Vaccine
clinicaltrials.gov

Oncophage
- Antigenics
Heat Shock Protein

NV1020 - Oncolytic Virus
- MediGene AG
Oncolytic Virus

Autologous Tumor Lysate-Pulsed Dendritic Cell
- Hospital - Jonsson Comprehensive Cancer Center
Dendritic Cell Vaccine

Autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine
- Milton S. Hershey Medical Center
Autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine

Cotara
- Peregrine Pharmaceuticals
Non-Vaccine - Cotara - TNT (tumor necrosis therpy)

Monoclonal Antibody 3F8
- Sloan-Kettering
Monoclonal Antibody

Novo-TTF device
- NovoCure Ltd
MicroWave

Dana Farber Cancer Institute
Drug: sargramostim
Drug: telomerase: 540-548 peptide vaccine
Procedure: colony-stimulating factor therapy
Procedure: non-tumor cell-derivative vaccine therapy
clinicaltrials.gov

M.D. Anderson Cancer Center
GOODWIN FOUNDATION
Biological: PEP-3-KLH
clinicaltrials.gov

Message 23722941
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext